Referenzen
Produkte Transfektion
Kostenlose Testsamples
Anwendungshinweise:
Im „Transfection Reagent Selection Guide“ können Sie durch Filterfunktionen z.B. für Ihre Kombination aus zu transfizierender Zelle und Nukleinsäure die Liste vorhandener Referenzen durchsuchen. Ebenso können Sie im Feld „Referenzen durchsuchen“ am Anfang der Seite mit passenden Schlagwörtern zu einem Ergebnis gelangen. Eine Referenz zeigt an, dass das gefundene Transfektionsreagenz bereits erfolgreich für die entsprechende Anwendung verwendet wurde. Im Idealfall sind getestete Transfektionsparameter und Transfektionseffizienzen angegeben.
Keine Referenz? > Allgemeine Auswahlhilfe
Wenn Sie keine Referenz gefunden haben, heißt das nicht, dass kein passendes Reagenz zur Verfügung steht, sondern lediglich, dass bisher keine Erfahrungsberichte vorliegen. In diesem Falle kann durch eine Vorauswahl ein erfolgsversprechendes Transfektionsreagenz ausgewählt (Allgemeine Auswahlhilfe) und letztendlich ausgetestet (Kostenlose Testsamples) werden. Wenn Sie einen Erfahrungsbericht für uns schreiben möchten machen wir Ihnen ein Angebot für eine Gegenleistung.
CELL TYPE | DESCRIPTION OF CELL TYPE | CAT.NO. | SPECIES | ORIGIN OF CELLS | COMMON CELL TYPE | GROWTH PROPERTIES | NUCLEIC ACID / DELIVERED MOLECULE | APPLICATION | PRODUCT | REFERENCE TYPE | BIBLIOGRAPHIC DATA | LINK | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
SKBR3 |
Human EpCAM-positive breast adenocarcinoma cell line | ATCC HTB-30 | Human | breast | cell line | adherent | oligonucleotide | Metafectene | publication | A. M. Tamaddona et al., Iranian J. of Pharm. Sci., 2011, 11: 7(2): 79-87 | Link | ||
SkBr3 |
Human EpCAM-positive breast adenocarcinoma cell line | ATCC HTB-30 | Human | breast | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | N. Golkar et al., Int. J. of Pharmaceutics, 2016, 510: 30-41; doi.org/10.1016/j.ijpharm.2016.06.026 | ||
SKBR3 |
Human EpCAM-positive breast adenocarcinoma cell line | ATCC HTB-30 | Human | breast | cell line | adherent | oligonucleotide | Metafectene | publication | C. Cava et al., Theranostics, 2020, 10(1): 50-61, doi: 10.7150/thno.36274 | Link | ||
SK6 |
Swine kidney cell line | Swine | urinary system | cell line | plasmid | Metafectene | publication | T. Krey et al., J. Virol., Apr 2006; 80: 3912 - 3922 | Link | ||||
SK6 |
Swine kidney cell line | Swine | urinary system | cell line | plasmid | Metafectene | publication | T. Walther et al., J. Virol., 2021, 95(11): e00154-21, doi.org/10.1128/JVI.00154-21. | Link | ||||
SK6 |
Swine kidney cell line | Swine | urinary system | cell line | plasmid | Metafectene | publication | D. Dubrau et al., PLOS Pathogens, 2017, DOI:10.1371/journal.ppat.1006134 | Link | ||||
SK-N-SH |
Human neuroblastoma cell line | ATCC HTB-11 | Human | brain | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | Z. Ping et al., Cell Cycle, 2012, 11: 10, 1999-2005, doi.org/10.4161/cc.20402 | Link | |
SK-N-BE(2) |
Human neuroblastoma cell line | ATCC CRL-2271 | Human | brain | cell line | adherent | plasmid | RNA-Interference | Metafectene | publication | A. Bertoni et al., J. Biol. Chem., 2011, 286 (6): 4727–4741, DOI 10.1074/jbc.M110.156521 | Link | |
SK-MEL-3 |
Human skin malignant metastatic melanoma cell line | ATCC HTB-69 | Human | skin | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | S. Romano et al., Pigment Cell Melanoma Res., 2013, 26: 900–911, doi: 10.1111/pcmr.12144 | ||
SHEP-SF |
Human neuroblastoma cell line | Human | unknown | cell line | adherent | plasmid | Metafectene | publication | T. Müller et al., Mol. Biol. Cell, Jan 2007; 18: 201 - 210 | Link | |||
SH-SY5Y |
Human neuroblastoma cell line | ATCC CRL-2266 | Human | bone | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene | application note | ![]() |
||
SH-SY5Y |
Human neuroblastoma cell line | ATCC CRL-2266 | Human | bone | cell line | adherent | plasmid | stable transfection | Metafectene | publication | F. Walter et al., Cell Death and Differentiation, 2015, 22: 1502-1516; doi:10.1038/cdd.2014.241 | Link | |
SH-SY5Y |
Human neuroblastoma cell line | ATCC CRL-2266 | Human | bone | cell line | adherent | plasmid | Metafectene | application note | ![]() |
|||
SH-SY5Y |
Human neuroblastoma cell line | ATCC CRL-2266 | Human | bone | cell line | adherent | plasmid | stable transfection | Metafectene | publication | K. M. Danzer et al., J. Neurosci., Aug 2007; 27: 9220 - 9232 | ||
SH-SY5Y |
Human neuroblastoma cell line | ATCC CRL-2266 | Human | bone | cell line | adherent | oligonucleotide | Metafectene | publication | K. Nolan et al., Europ. J. of Neuroscience, 2016, 43: 640-652; doi:10.1111/ejn.13160 | |||
SH-SY5Y |
Human neuroblastoma cell line | ATCC CRL-2266 | Human | bone | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | S. Kim et al., Mol. Cell Biol., 2015, 35:1754-1762; doi:10.1128/MCB.01325-14 | Link | |
SH-SY5Y |
Human neuroblastoma cell line | ATCC CRL-2266 | Human | bone | cell line | adherent | plasmid | Metafectene | application note | ![]() |
|||
SH-SY5Y |
Human neuroblastoma cell line | ATCC CRL-2266 | Human | bone | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | K. Wanget al., Cell Mol. Neurobiol., 2016, 36:603-611; DOI 10.1007/s10571-015-0241-3 | ||
SH-SY5Y |
Human neuroblastoma cell line | ATCC CRL-2266 | Human | bone | cell line | adherent | plasmid | cotransfection (plasmid/siRNA) | Metafectene | publication | S. Kim et al., Mol. Cell Biol., 2015, 35:1754-1762; doi:10.1128/MCB.01325-14 | Link | |
SH-SY5Y |
Human neuroblastoma cell line | ATCC CRL-2266 | Human | bone | cell line | adherent | plasmid | stable transfection | Metafectene | application note | ![]() |
||
SH-SY5Y |
Human neuroblastoma cell line | ATCC CRL-2266 | Human | bone | cell line | adherent | plasmid | Metafectene | publication | P. Aridon et al., Parkinsonism and Related Disorders, 2016, 31:135-138, doi.org/10.1016/j.parkreldis.2016.08.016 | |||
SH-SY5Y |
Human neuroblastoma cell line | ATCC CRL-2266 | Human | bone | cell line | adherent | plasmid | Metafectene | publication | T. Engel et al., Brain, Feb 2013; 136: 577 - 592 | |||
SH-SY5Y |
Human neuroblastoma cell line | ATCC CRL-2266 | Human | bone | cell line | adherent | plasmid | stable transfection | Metafectene | publication | M. C. Hogg et al., Brain Commun., 2020, 1 of 17, doi:10.1093/braincomms/fcaa138 | Link | |
SH-SY5Y |
Human neuroblastoma cell line | ATCC CRL-2266 | Human | bone | cell line | adherent | plasmid | Metafectene | application note | ![]() |
|||
SH-SY5Y |
Human neuroblastoma cell line | ATCC CRL-2266 | Human | bone | cell line | adherent | plasmid | Metafectene | publication | N. .J. Bradshaw et al., PLoS ONE, 2014, 9 (10): e111196, doi:10.1371/journal.pone.0111196 | Link |